# High Dose Ace Inhibitor Therapy Versus Combination of ACE and ARB Therapy

> **NCT00212901** · NA · COMPLETED · sponsor: **Ottawa Hospital Research Institute** · enrollment: 30 (estimated)

## Conditions studied

- Diabetic Kidney Disease

## Interventions

- **DRUG:** High dose ACE-I vs ARB

## Key facts

- **NCT ID:** NCT00212901
- **Lead sponsor:** Ottawa Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** —
- **Final completion:** 2006-09
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2007-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00212901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00212901, "High Dose Ace Inhibitor Therapy Versus Combination of ACE and ARB Therapy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00212901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*